Opportunity

SAM #NOI-OLAO-CC-27-001197

Luminex ELITE service coverage for two FM3D instruments

Buyer

NIH Clinical Center

Posted

November 19, 2026

Respond By

December 04, 2026

Identifier

NOI-OLAO-CC-27-001197

NAICS

334516

NIH Clinical Center intends to obtain service coverage for two Luminex FM3D instruments used by its HLA Lab. - Government buyer: National Institutes of Health Clinical Center (NIH-CC), U.S. Department of Health and Human Services; end user is the HLA Lab. - OEM and intended service provider: Luminex Corporation. - Requested service: ELITE service agreement for two FM3D instruments, including unlimited emergency repair visits with travel, parts, and labor; two preventive maintenance visits per year; priority scheduling; certain software updates and modifications; and 24/7 telephone and online support. - Response requirement: On-site repair response within one business day after a repair dispatch is determined. - Procurement approach: The agency identifies Luminex as the intended sole source for this service.

Description

This is a Notice of Intent, not a request for proposal.  The National Institute of Health, Clinical Center (NIH-CC) intends to negotiate on an other than full and open competition basis with the following vendor: Luminex Corporation.

Acquisition Description:

The service agreement is for two FM3D instruments that are used by the HLA Lab for daily testing of transplant patients and donors. The instruments are utilized to provide low resolution HLA typing results for multiple protocols at the NIH. Several of these protocols are for transplants. The ELITE Service Plan provides the following coverage: • Unlimited visits for emergency repair (includes travel, parts and labor) • Two preventative maintenance visits per year • Priority scheduling for service requests • Certain software updates and modifications • Telephonic and online support 24 x 7 Response Time: On-site one business day response time for repair service. On-site arrival by end of next business day when dispatch determination is made by 6pm Central Standard Time (CST). This level of service and response is required by the HLA Lab to ensure the instruments are functioning properly. Any down time to an instrument can result in delayed testing turn-around time. Many of the patients who utilize the HLA Lab services are transplant patients and donors. Prompt testing is essential for the transplant protocols.

The statutory authority for this sole source requirement is 41 U.S.C. 253(c) (1) as implemented by FAR 6.302-1 only one responsible source and no other supply of service will satisfy agency requirements. THIS IS NOT A REQUEST FOR PROPOSAL.  All responsible sources that could provide the required may submit a capability statement that will be considered by email (subject line to reference NOI-OLAO-CC-27-001197) by 12:00 PM eastern standard time on 12/04/2026 to: valerie.gregorio@nih.gov.

All responses received by the closing date of this synopsis will be considered by the Government.  A determination not to compete this requirement, based upon responses to this notice, is solely within the discretion of the Government.

View original listing